Recombinant Human Urokinase/uPA Protein (His tag)
SKU: PDMH100158-100
To better serve you, we would like to discuss your specific requirement.
Please Contact Us for a quote.
Recombinant Human Urokinase/uPA Protein (His tag)
SKU # | PDMH100158 |
Expression Host | HEK293 Cells |
Description
Synonyms | ATF, BDPLT5, PLAU, QPD, U-Plasminogen Activator, UPA, URK, Urokinase-Type Plasminogen Activator, u-PA, uPA |
Species | Human |
Expression Host | HEK293 Cells |
Sequence | Met1-Leu431 |
Accession | P00749 |
Calculated Molecular Weight | 47.3 kDa |
Observed Molecular Weight | 45 kDa |
Tag | C-His |
Bio-activity | Not validated for activity |
Properties
Purity | > 95% as determined by reducing SDS-PAGE. |
Endotoxin | Please contact us for more information. |
Storage | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Shipping | This product is provided as lyophilized powder which is shipped with ice packs. |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5%-8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Reconstitution | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis. |
Background
Recombinant Human Urokinase-Type Plasminogen Activator is a serine protease, which specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. Human Urokinase-Type Plasminogen Activator is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide residues. The single chain molecule is processed into a disulfide-linked two-chain molecule. There exists two forms A chain, the long A chain contains an EGF-like domain that is responsible for binding of the uPA receptor. The B chain corresponds to the catalytic domain.